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PROPRIETARY MEDICINE A RECENT DEVELOPMENT.
The proprietary medicine business as we know it is a
development of only a little over a generation. In 1875,
Lawrence, of Medical Brief fame (?), and his junta of
nostrum makers, whose output and that of their off-
shoots alone have run into the hundreds, were unknown.
Thirty years ago the so-called German synthetic
chemicals were unheard of as medicines; now,
if we include the true and the false, there are
thousands of them. Including the typical nostrums,
the more or less legitimate proprietary mixtures and the
synthetic compounds, the number of proprietary medi-
cines has become so vast that no one is rash enough
to attempt to estimate it. A few of these, we may
admit, have a distinct value; they represent original
work and are worthy of recognition as remedial agents.
The vast majority, however, are but the simplest of
mixtures or are well-known drugs put out under fanci-
ful names, with no advantage whatever; or are abso-
lute frauds and swindles. Some of these remedies are
made by manufacturing pharmaceutical and chemical
houses of greater or less repute; the majority by men
—or "companies"—who know nothing about medicine,
pharmacy or chemistry, and who have gone into the
business as they might have gone into any other get-
rich-qnick enterprise.
This business has been growing more rapidly than
ever during recent years, and the statement made here
in Baltimore last December that the use of this class of
preparations has doubled during the last decade is prob-
ably true. But worse than the increase in number is
the development in the advertising literature of un-
blushing falsehood and palpable deception. Conditions
in this regard had become so disgraceful—I put this in
the past tense because there has been a change since the
Council began its work—that there seemed to be no
statement too silly, no claim too extravagant, and no
falsehood too brazen for use by those who wrote the
advertising literature that physicians were asked to
read and to believe. It was, therefore, not only the
character of the preparations, but the methods of ex-
ploitation that had become unbearable and a disgrace
to the profession that tolerated it. In brief, this busi-
ness, the annual profits of which run into the millions,
has grown until the use of proprietary medicines by
many physicians has almost displaced the use of the
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individual officiai drug. It has checked advance in
scientific methods of treatment, inhibited intelligent
clinical observation and developed an optimism that is
unwarranted by facts—an optimism that is more fatal
than the most radical therapeutic nihilism. But above
and worse than all, this commercialized materia medica
has blighted our literature by debauching our medicaljournals and even by tainting our text-books.
And whose is the fault? That the business has de-
veloped in this country to such extent, with scarcely a
protest on the part of our profession, is a reflection
on the common sense and intelligence of the physicians
of the United States. We, as well as manufacturers,
are at fault. We must assume the blame for becoming
such easy dupes to their enterprise and sagacity.
But a change is taking place; a halt has been called,
and our profession is awakening to the disgrace of it
all. It is about the movement for ridding our profession
of this disgrace that I want to speak to-night.
NO PROTECTION IN THE PAST.
We have long suffered from a want of governmental
or other supervision over the manufacture of medicines-
In no other country has the standard and quality ofdrugs been left entirely to the manufacturer's honor.
From time to time the medical profession has made
spasmodic, but weak, efforts to remedy the condition :
we find records of this even as early as the beginning ofthe nineteenth century.
The agitation of those early days resulted in the
adoption of a Pharmacopeia, the first issue of which was
published in 1820. This standard, by the way, was the
work of physicians and was gotten out by them for theguidance of pharmacists, who, however, had nothing todo with its preparation. It is to be regretted that con-
ditions have changed, and that, while the physicians
then were the ones interested, for the last fifty yearsthey have left it practically to the pharmacists. Whilethe Pharmacopeia furnishes standards which were ac-
cepted by a few as authoritative, it was, after all, but
an advisory instrument, and was followed or ignored
as suited the manufacturer.
The Pharmacopeia only partially improved matters,
and society transactions continued to contain records
of criticisms of the prevailing conditions. So it went
on until the organization of the American MedicalAssociation. At its first meeting resolutions were
adopted indicating that the question was still a vital
one. So, again, in 1849, 1850 and every year or two
thereafter this subject was discussed. Then, however,
the unreliability of drugs was the source of irritation,the proprietary medicine abuse not yet being so much in
evidence. In 1879 we first find the Association recog-
nizing that incipient evil which has since developed intothe modern curse—proprietary medicines. In the
Transactions for that year we find the following:
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Whereas, Of late year» many drug» and combinations of drugsbearing copyright names have been placed on the market and
especially introduced to the notice of physicians, and
Whereas, Such drugs and combinations of drugs, having copy-
righted names, are advocated in the medical journals of the country,be it
Resolved, That the use of articles thus protected by copyright
and the promoting of their use by advertising them In medicaljournals is a distinct violation of Section 4, Article 1, of that
portion of the Code of Ethics treating on the duties of physicians
to each other and to the profession at large, and also of Section 4,Article 1, of that portion of the Code of Ethics treating on theduties of the profession to the public and of the obligations of thepublic to the profession. (Transactions, vol. xxx, 1S79, p. 45.)
From this time on scarcely a year passed that the
Association did not take action regarding the proprie-
tary-medicine problem, and finally when The Journal
took the place of the annual Transactions it became, on
account of the advertisements, a very practical question.It is worth recording here that there was a time when
our profession opposed proprietaryship in medicines,
recently, however, this seems to be accepted as a neces-
sary evil.
IMPOSSIBLE TO DEFINE AN "ETHICAL" PROPRIETARY.
It is unnecessary to give in detail the difficulties con-
nected with this question, or to explain how absolutely
impossible it has been to decide what is and what is not
an ethical1 proprietary preparation. It certainly has
been a trying question for those editors who have hon-
estly striven to have their advertising pages clean and
free from fraud. But long ago it was realized that the
problem is one that the physician can not solve by him-
self. A physician is not supposed to be an authority
on pharmacy and chemistry ; he is expected to know the
physiologic and therapeutic actions of drugs, but not the
details of their chemical action or the intricacies of
their compounding. This requires a special training
and a technical knowledge entirely different from that
required for prescribing for the sick.
The pharmaceutical profession bears the same relation
to the medical profession that the ordnance department
does to the army in the field. The fighting force is not
expected to know how to make a rifle, or to have a prac-
tical understanding of the manufacture of powder and
shot. The men on the firing line know- how to use, but
not how to make the ammunition. But nevertheless the
efficiency of the men at the front is largely dependent
on the integrity and honesty of the supplies of the ord-
nance department.
The trouble has been that the sister professions of
medicine and pharmacy have not been cooperating;
rather they have been drifting apart.
It was in recognition of this principle that, in 1900,
there was published in The Journal a series of articles,
written by a pharmacist well qualified for the purpose,
on "The Eolation of Pharmacy to the Medical Profes-
sion." Their object was to enlighten the profession re-
gnrding the conditions with the purpose of leading up to
the suggestion of a remedy. As may be remembered, the
remedy suggested was the creation of a body of pharma-
cists, chemists and pharmacologists who should act for
the profession and examine the products on the market,
or at least take up the subject from a practical stand-
point. These articles appeared just before the first
Atlantic City session, and some of us had a vague idea
of proposing such a board to the general meeting, but
the psychologic moment did not seem to have arrived
and the matter, for the time being, was dropped.
And so time went on, the subject receiving; more or
less attention in the Section on Pharmacology and
1. I am well aware that we should not apply the word "ethical"
to an inanimate object. I use It because it seems to be necessary.
Therapeutics at each annual session, till at the Atlantic
city session, in 1904, the delegates from Michigan pre-
sented to the House of Delegates a preamble and reso-
lutions that had been adopted by their state society,
which read as follows:
Whereas, An exact knowledge of the composition and properties
of substances used In the management of disease is essential to a
physician's best success :
Whereas, Commercial push, by advertisement and drummers,persuades many physicians (often the very elect), to use and com-
mend drugs, mineral waters, artificial foods, etc., etc., of unknown
composition and effects :
Whereas, As it Is impossible for the Individual physician to
verify the statements of sales agents, to separate fact from fancy,
he often uses substances quite unlike those indicated, to the dis-
credit of himself and his art :
Whereas, The American Medical Association was organized to
promote tha exact knowledge and intelligent practice of its mem-
bers :
Resolved, That the Board of Trustees, American Medical Asso-
ciation, is hereby requested to provide for the analysis of medicinal
substances of unknown composition and undetermined effects, and
to publish promptly the results in the Association Journal :
Resolved, That the Board of Trustees be requested to appoint a
"Journal Clearing House Commission," three in number, to serve
without salary, with authority to have analyses made in reliablelaboratories, by experts of recognized ability, or to equip a suitable
laboratory and employ one or more competent experts, at a yearly
expense not to exceed five thousand dollars.
THE COUNCIL CREATED.
While these resolutions were not finally acted on, some
of us realized that the time had at last arrived for some-
thing to be done, and for materializing the idea of a
board of control. During the next eight months the
general plan was discussed with many physicians and
with such chemists and pharmacists as Professors Long,
Stieglitz, Puckner, Hallberg and others of Chicago,
Professor Cushny of Ann Arbor (now of London),
Professor Abel of Johns Hopkins, Dr. Wiley and some
of his staff at Washington, Professor Bemington, Pro-
fessor Sadtler, Mr. Wilbert of Philadelphia, Dr. Soll-
mann of Cleveland, and others. Several meetings were
held, at which a few gathered and the general plan and
scope of the work was outlined and discussed in all its %
phases. The matter was presented in detail to the Board
of Trustees at its meeting in February, 1905. After
discussing the matter fully the trustees authorized the
creation of the board, and specified that it be known as
the Council on Pharmacy and Chemistry.
Thus it is that the profession now has at its service
a group of men who, for this work, possess special train-
ing and technical knowledge. Their energies are de-
voted to the thankless task of winnowing from the chaff
of dishonesty the occasional grain of honesty.
The first meeting of the Council was held in Pitts-
burg, Feb. 11, 1905. This meeting was an interesting
one. To me it was not only interesting, but profitable,
for my eyes were opened to conditions the very existence
of which I had not before realized. Among those pres-
ent were practical pharmacists, practical chemists, well-
trained pharmacologists and physicians. Each group
saw things from its own viewpoint, compared notes and
exchanged views. As I say, the result was interesting
and the revelations both instructive and—humiliating.
The work to be accomplished at this meeting was to
lay down certain fundamental principles that should
govern the Council in its labors, to devise methods of
procedure, etc. The most serious and important phase
of the work was the adoption of the rules or principles
which should govern the Council in deciding whether
or not a preparation should be accepted.
The first thing an intelligent physician does when he
is called to treat a patient is to make a diagnosis of the
disease, learn its cause, and remove it if possible. On
this principle the Council attacked the problem.
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RULE 4.-INDIRECT ADVERTISING TO THE PUBLIC.
It was recognized at the outset that the first objec-
tion to proprietary medicines is that the prescribing
of such preparations is apt to lead to self-medicationby the public and the manifest evils which this entails.
The fact that physicians themselves are responsible for
at least some of the "patent medicine" business is well
known to every pharmacist and to every physician who
has given the matter thought. A physician writes a
prescription for a proprietary preparation that has a
catchy, easily remembered name, and thinks that
the matter ends there, but the manufacturer knowsbetter; the patient gets the medicine, and with it
all kinds of information regarding its virtues. The
physician may instruct that the label, circulars, etc., be
removed, but in many cases this is not done, and usually
no such instruction is given. The patient learns from
the printed matter that that particular medicine is good
not only for the disease for which the doctor prescribedit, but for every other real or imaginary ailment with
which he may be afflicted. In this way there has been
introduced to the public a host of "patent medicines"
without a cent of cost for advertising, except that to
physicians.
The full directions for use which accompany these
medicines are, in part at least, responsible for counter-
prescribing by druggists. There is a peculiar fascina-
tion—at least to the average pharmaceutical tyro—in
posing as a prescriber, exemplifying the old saying : "A
little knowledge is a dangerous thing." The "proprie-
tary" nostrum vendors give him the "little knowledge,"
sufficient, that is, to sell their preparations. He soon
becomes familiar with the reading matter and he is
impressed, or pretends to be, with the wonderful proper-
ties of the preparation as described in the circulars. He
adds his recommendation to those of the doctors whose
testimonials he shows to the customers on the other side
of the counter.
This indirect advertising to the public was the first
evil to be overcome, and the first principle adopted by
the Council is incorporated in what is now known as
Bule 4. It is as follows :
No article will be admitted whose label, package or circular
accompanying the package contains the names of diseases in
the treatment of which the article is indicated. The therapeutic
indications, properties and doses may be stated. (This rule
does not apply to literature distributed solely to physicians, to
advertising in medical journals, or to vaccines and antitoxins.)
It is this rule that has met with opposition from those
who are not satisfied with the doctors' patronage, but
want that of the public also. It is this rule that is of
most importance to the physician, for its enforcement
will check one of the worst evils connected with the pro-
prietary medicine business—that which makes the doc-
tor an advertising medium to the public.
Certain manufacturers oppose it because, they say,
the doctor needs the information and the instruction
that is given on the labels and in the circulars. The
reply is that it is not necessary for the doctor to go to
the drug store to learn what a remedy is good for, even
though he is one of those who depend on the manufac-
turer for his knowledge. If a doctor dispenses his own
medicine and has to depend on the manufacturer for
information regarding its use, let that information be
given in the literature not attached to the package.
Medicines manufactured solely for physicians' use,
such as the official preparations and those of the Na-
tional Formulary, are not accompanied with circulars or
advertising matter and there is no valid reason why
proprietary medicines should be. If the manufacturer
wants to enlighten the doctor regarding the value of his
preparation, let him advertise in the medical journals;
let him send the circulars, or his detail man, to the doc-
tor direct; in any event, there are many ways of letting
the doctor know in what diseases the medicine is indi-
cated without putting it on the bottle. It will be no-
ticed that Bule 4 permits therapeutic properties and
doses to be given in the literature accompanying the
package. Many believe, and with good reason, I think,
that the Council has been too liberal in this, that no
such information is necessary in that connection.
It has become a recognized fact in the "patent-medi-
cine" field that the easiest and cheapest way of reaching
the public is by advertising through the doctor. Let
me quote a paragraph that appeared in Printers' Ink,
an advertising journal, some two or three years ago.
The words are those of a "patent medicine" man and, of
course, were not directed to physicians.
But the patent medicine of the future is the one that will be
advertised only to doctors. Some of the most profitable rem-
edies of the present time are of this class. They are called pro-
prietary remedies. The general public never hears of them
through the daily press. All their publicity is secured through
the medical press, by means of the manufacturer's literature,
sometimes gotten out in the shape of a medical journal, and
through samples to doctors. For one physician capable of pre-
scribing the precise medicinal agents needed by each individual
patient there are at least five who prescribe these proprietaries.
They are the chief standby of the country practitioner. . . .
Three-fourths of all the prescriptions received are for these
proprietary remedies, and the pharmacist simply opens the
package and writes a label, "A teaspoonful three times a day
before meals."
. .
.
The original bottle is given to the
patient. He sees that the remedy does him gcod, and when he
feels a trifle run down again he goes to a drug store and buys
another bottle, not troubling the doctor. He meets a friend on
the street who is not looking well. "I know exactly how you
feel," he says. "Now, just go and buy a bottle of-. Best
thing in the world. My doctor prescribed it for me, so it isn't
a 'patent medicine.' " In this way the name of the remedies
advertised only to physicians get abroad to the general public.
.
.
.
The proprietary medicine of the future, though, will
be advertised through these channels. The medical papers will
reap the harvest, and the physician himself, always so loud in
the denunciation of "patent medicines," will be the most im-
portant medium of advertising at the command of the proprie-
tary manufacturer. In fact, he is that to-day.
Have you ever seen an arraignment of this evil byits enemies which equals this cynical statement of its
friends ?
Is it necessary to say more on this point? In fact,
can anything more be said? What I have just quoted
should be read by every nostrum-prescribing doctor in
the country, and, having read it, he should go to some
quiet corner and kneel down and pray the Lord to givehim a little common sense.
Now, while I am quoting, let me quote something
else. This is from a book written by Mr. George P.Bowell, entitled "Forty Years an Advertising Agent."
Mr. Bowell, as some of you may know, dabbled somewhatin the "patent medicine" business himself. He is the
one who created Bipans Tabules. In this book, by the
way, he tells how he came to put this preparation on the
market. In the chapter from which I shall quote he de-
scribed the "patent medicine" business in an interesting
way, and tells of the fortunes that have been made and
also lost. He has this to say about an "ethical" pro-prietary that some of you may have heard about :
We had a successful advertiser in Halifax, N. S., who sold
a medicine known as Fellows' Hypophosphites, that proved so
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gcod that some shrewd business men in the medicine trade,
who knew about it, bought the trade-mark, incorporated a
company with a capital of $100,000, retained the original
owner as manager, stopped all advertising except in medicaljournals, and thereafter pushed the sale only through the
medical profession. I had information at one time of a young
man who was heir to an uncle, recently deceased, and had
conic into possession of a certificate of stock of this company,
of the face value of $0,000, and made up his mind that, shrewd
as the old gentleman was, he had, without doubt, acquired trash
in this instance; and I heard further, that the young man
began to think better of the doubtful asset, when one day a
dividend check came; and when, at the end of the year, he
 
realized that within the twelvemonth that $0,000 certificate
had brought him $0,000 in dividends, he began to revise his
estimate of his deceased uncle's prescience in making invest-
ments.
As a "patent medicine" it was not a success, but
as an "ethical proprietary" it has been proving a gold
mine. So, since that time this medicine has not been
advertised except to doctors through medical journals,has it? Look at the wrapper around the bottle, read
the label on the bottle, notice the name blown into
the bottle, and then will you doubt the statement of
the average druggist when he says that nine-tenths
of Fellows' Hypophosphites is sold over the counter di-
rect to the public and that the doctors are responsible?
What better method of advertising? And how easy!
Newspaper advertising is expensive! It is cheaper to
use the doctor.
The principle incorporated in Bule 4 is one of the
most important principles adopted by the Council. It
threw out at once three-fourths of the proprietary medi-
cines on the market. For is it to be supposed that the
promoters of Fellows' Hypophosphites, Gray's Glycerine
Tonic, Glycothymoline, Antikamnia, Antiphlogistine,
Phenalgin, Santal Midy, and most of the self-styled
"ethical" proprietaries would conform to Bule 4 ? From
their standpoint the proposal is absurd.
RULE I.—NON-SECRECY.
Everybody, that is, nearly everybody, agrees that a
physician should know what he prescribes. Some inti-
mate that he has no moral right to give a medicine
unless he knows what he is giving. A few emphatically
express the tfiew that it should be made a criminal
offense for a physician to give a patient a medicine
when he does not know exactly what it contains. I
must acknowledge that I am much tempted to side
with the latter. In any event, after agreeing on Bule
4, the Council again went back to general principles,
and adopted the following, which is known as Bule 1 :
No article shall be admitted unless its active medicinal in-
gredients and the amounts of such ingredients in a given
quantity of the article be furnished for publication. The gen
eral composition of the vehicle, its alcoholic percentage, if any,
and the identity of other preservatives, if present, must be
furnished. ,
There was little discussion when this rule was under
consideration. Even the verbiage was soon agreed to.
It is so palpably consistent, so absolutely fair and just
that one would have imagined that it wTould receive uni-
versal approval. But do you remember the protests of
certain medical journals when the first announcement
was made and these rules published? It was sim-
ply outrageous, we were told, that enterprising firms
which had spent money and time in getting up a fine
combination should be asked to state what the combina-
tion contained. One New York medical journal even
went so far as to send a circular letter to the manufac-
turers offering them space in its columns for an expres-
<
sion of their views in regard to the outrageous attempt
that was about to be made to injure their business. Cer-
tainly, this attack on vested interests was scandalous,
and it was a good thing that the proprietary people
were so well guarded by a journal that is published in
the interests of physicians.
But the proprietary gentlemen were too wise: they did
not accept the offer, since nothing appeared from them.In fact, the majority of the nostrum men have said that
they always have been, still are, and always will be will-
ing to tell physicians what their preparations contain.
They agree that physicians should know what they areprescribing, that it is very necessary they should know.It would be wrong, indeed, if physicians should pre-
scribe without knowing what they are prescribing, say
these gentlemen. Surely! And the more quackish the
preparation and the "company" that exploits it, the more
willing they are to give a formula. Mind you, I say "a"
formula.
When some twelve years ago the Board of Trustees
ordered that no proprietary should be advertised in The
Journal, unless the advertisement was accompanied
with a formula sufficiently often to let the reader know
of what the preparation consisted, they imagined that
they had done away with the evil—secrecy. And this
has been the cry since—publish the formula and the
preparation becomes ethical. It did not seem to dawn
on those who were especially interested in this subject
that connected with the exploitation of the proprie-
taries were most extravagant claims as to their thera-
peutic value, and that those who would make mis-
statements regarding the therapeutic action of their
preparations would not hesitate to stretch the truth
when they made statements as to the composition. Theformula was the thing. If the formula was forthcoming,
the preparation was ethical. But it has developed
that the more fakish the nostrum the more willingly
was the formula furnished. So it is not strange that
there were admitted to the advertising pages of
The Journal such fakes as Ammonol, Phenalgin, La-
bordine, Campho-Phenique, Salacetin, Hagee's Cordial
of Cod Liver Oil Compound and Tyree's Antisepiic
Powder.
The idea that the publication of a formula will make
a preparation ethical has been harped on and emphasized
until many believe it. Now the fact is most of the pro-
prietary mixtures are simple combinations of well-known
drugs that any pharmacist, or even an average physician,
could compound if the active ingredients were known.
Therefore, would not the makers of such preparations
be very foolish to give the correct formula even as to the
active ingredients? Surely they would be, and the aver-
age nostrum maker is not a fool.
I presume it is unnecessary to say that the Council
is not satisfied with "a" formula, but demands "the"
formula.
RULE 6.—EXTRAVAGANT THERAPEUTIC CLAIMS.
The man who has something to sell naturally wants to
impress the prospective buyer with all its good qualities.
This is business—honorable business. Incidentally, in
the business world it is expected that the seller, while
emphasizing all the good qualities, will tell the truth. An
exception to this rule may be made to the horse-trader.
He, proverbially at least, is expected to overstep the
bounds of truth in his comments on the quality of his
animal. But the other gentleman knows this and dis-
counts his statements accordingly. He examines the
animal, or if he thinks himself deficient in the necessary
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knowledge to pass judgment on the value of a piece of
horse flesh he gets the advice of a friend who has this
knowledge.
I admit it is rather far-fetched to compare horse-
trading with a proprietary medicine business, but
there docs seem to be a similarity—and also a dif-
ference. The seller in both instances is given to a
slight exaggeration as to what the respective articles will
do in their respective spheres of action, but in one case
the buyer, at least as a rule, takes it for granted that the
seller is likely to stretch the truth. At least, he is
healthily skeptical about the matter and does not believe
all that the horse-trader says. In the other case the
buyer, to borrow a simile from another department of
life's activities, is quite likely to swallow not only the
bait, but the tackle also. Perhaps he is not so much
to blame after all. It is a little difficult for honest
physicians to realize that others traffic in human life.
The claims in the advertisements of "patent medi-
cines" are so absurdly extravagant that a "patent medi-
cine" advertisement has become synonymous with men-
dacity. In too many instances this also applies to ad-
vertisements of so-called "ethical proprietaries." There
is no limit to the license allowed those who write the ad-
vertising matter that is to influence physicians to use
the products advertised.
To repeat again, there seems to be something con-
nected with the "patent" and proprietary medicine busi-
ness that demoralizes. An honest, conservative statement
about the merits of a proprietary preparation is as rare
as are sweet violets in Iceland. As regards the large
majority this is not to be wondered at. To tell the truth
about cither their composition or their therapeutic value
would be to stop their sale. But there are proprietary
medicines that have merit and that would be used even
if the simple, unvarnished truth were told about them,
but the habit of exaggeration crops out in the advertis-
ing of even these.
This was one of the evils recognized and so Bule 6
was adopted, which says:
No article will be admitted or retained of which the manu-
facturer or his agents make unwarranted, exaggerated or mis-
leading statements as to therapeutic value.
Of course, the principle underlying this rule is so
elemental that one might think that it would meet
with no opposition when put into practical application.
Yet its actual enforcement has caused much trouble in
spite of the fact that there has been a liberal interpre-
tation of the literature. The diversity of opinion and
varied experience in the use of therapeutic agents hasbeen recognized and the Council has admitted every
reasonable claim, everything short of absolute misstate-
ment and palpably false pretension.
OTHER RULES.
The three rules above considered meet the most objec-
tionable features of proprietaryship in medicine. Indi-
rect advertising to the public through the physician,
secrecy in composition and false therapeutic claims. The
enforcement of these three rules would do away with the
main evils connected with the proprietary business, and
incidentally would wipe out a goodly number of the
products. The other seven rules, while important, some
of them being necessary for the enforcement of the three
already referred to, need but a brief reference here.
Eule 2 is:
No chemical compound will be admitted unless sufficient
information be furnished regarding tests for identity, purity
and strength, the rational formula or the structural formula,
if known.
There are many preparations on the market, both
domestic and imported, that are claimed to be definite
chemical compounds, but which are not. This rule
guards against such, as well as against adulteration,
etc. No objection has been made to this rule.
Bule 3 says :
No article that is advertised to the public will be admitted;
but this rule will not apply to disinfectants and food prepara-
tions, except when advertised in an objectionable manner.
This rule, of course, refers to open, direct advertising
to the public, in the public press, etc. It is not neces-
sary to defend this rule, before physicians at least. It
provides for conditions entirely different from that cov-
ered in Bule 4.
Bule 5 is:
No article will be admitted or retained concerning which the
manufacturer, or his agents, make false or misleading state-
ments as to geographical source, raw material from which
made, or method of collection or preparation.
The proviso in this rule is incorporated in the na-
tional Pood and Drugs Act and needs no comment.
Bule 7 says:
Labels on articles containing "poisonous"' or "potent'' sub-
stances must show the amount of each of such ingredients in
a given quantity of the product. A list of such substances will
be prepared.
This rule is not really necessary since the passage of
the national Food and Drugs Act covers many of the
substances referred to.
Bule 8 is as follows:
If the trade name of an article is not sufficiently descriptive
of its chemical composition or pharmaceutical character, or is,
for any other reason, objectionable, the Council reserves the
right to include with the trade name a descriptive title in the
book. Articles bearing objectionably suggestive names will
be refused consideration.
The last sentence was not in the original draft; ex-perience showed the necessity of such a rule. I doubt if
any one will think this an unwise precaution when
we run across such names as : Gonosan, Gonorin, Gono-
ral, and Gonol, names certainly suggestive enough
even to the most ignorant layman, and remembered
without difficulty by those who wanted to tell their
fellow-sufferers what they were taking. Gcnitone, Yagi-
nol, Oöphorin, Virilin, Bheumasan, Bronchitin, Pneu-
min, etc., are others. I am not quoting fanciful namesfrom the "patent medicine" list; they are all advertised
to physicians as scientific preparations.
Bules 9 and 10 merely require information regarding
the copyrighted name and, if the article is patented, the
number and date of the patent. They are as follows:
Bule 9 :
If the name of an article is registered, or the label copy-
righted, the date of registration and a copy of the protected
label should be furnished the Council. In case of registration
in foreign countries, the name under which the article is regis-
tered should be supplied.
Bule 10 states:
If the article is patented—either process or product—the
number ond date of such patent or patents should be furnished.
These rules were adopted in a tentative way at the
Pittsburg meeting. In the following September theCouncil met at Cleveland and to that meeting were in-
vited representatives of the various branches of manu-
facturing and importing interests for consultation and
suggestion. The various rules were discussed and only
slight modifications were made. The only rule that was
objected to by the manufacturers' representatives was
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Bule 4, but all who took part in the discussion acknowl-
edged that the principle underlying the rule was a just
one and would work no hardship on those manufacturers
who were catering to physicians only.
At the Pittsburg meeting it was decided that when it
was necessary for the manufacturer to change the labels,
circulars, and other advertising matter, he should begiven ample time in which to comply so that he might
not experience undue expense or hardship in meeting the
requirement. At the Cleveland meeting this time was
extended definitely until July, 1906. Thus, previous to
July, 1906, the Council accepted preparations even
though the labels, literature, etc., might not have beenin accord with the rules, on the promise of the manufac-
turer to make the necessary modifications in a reason-
able time. However, since July 1, 1906, the literature,
labels, etc., must be correct before the preparation is ac-
cepted.
I have discussed these rules at length that you mayknow what they are and what they mean. Together theygive, wdiat has never been given before, a definition of the
term, "an 'ethical' proprietary medicine." Is it satis-
factory? Together they make the standard by which the
Council judges proprietary medicines. Is the standard
too high ?
PROCEDURE.
As the members of the Council are scattered, meet-
ings, except at rare intervals, are impracticable. The
method of procedure, however, is simple, communica-
tion between the members being through a bulletin pre-
pared and sent to each member by the secretary every
Thursday. In this bulletin are arranged systematically
the reports, motions, comments, discussions, etc., the
matter being indexed so that ready reference to all past
work is at hand for each member.
The Council is divided into three definite divisions—
chemistry, pharmacy and pharmacology. Articles are
assigned to a subcommittee usually consisting of but one
member for preliminary report. This subcommittee
consults with other members, with outsiders, and, if
thought advisable, makes or has made chemical analyses
or physiologic examinations. If the subcommittee de-
sires to communicate with the manufacturer, the cor-
respondence is conducted through the secretary of the
Council, the identity of the subcommittee not being di-
vulged.
When ready the report is placed in the Bulletin, to-gether with such correspondence or other matter that the
subcommittee may think necessary for the guidance of
the members in arriving at a conclusion. The report
may be preliminary or final. If preliminary, sugges-
tions and advice are asked. If final, the article is rec-
ommended for either Class A, B, C or D, and reasons
given for the recommendation. When the final report is
made, it is before the whole Council for action. If the
article is put in Class A, it means acceptance; if inClass B. more definite information regarding the com-
position is wanted; if in Class C, certain modifications
in the literature are required, and, if in Class D, it
means refusal of recognition.
The assignment of an article to Class A cf ¿lass D is
not necessarily final. If an article which Y ß been voted
to Class A is later found to conflict wit' ( the rules, the
action of the Council may be reconsi'' yreà. Similarly,
an article voted to Class D may again be taken up and
finally accepted if it is found that it has been made to
conform with the rules.
Many manufacturers, believing that the publication
of certain information in regard to their products would
detract from their value, have often volunteered to fur-
nish information for the private use of the Council. TheCouncil, however, does not receive trade secrets, hut in-
sists that all information it receives may be published at
its discretion. The Council desires information for the
profession, and not for itself alone.
CHEMICAL EXAMINATION NOT ALWAYS MADE.
It is needless to say that the Council does not make
chemical examinations of every remedy. Such a task is
manifestly impossible. If the authors of text-books on
physiology, on anatomy or on practice, were to verify
every statement they made, such works could not be
completed in a lifetime. Instead, the authors, by virtue
of their general knowledge of the subjects on which they
write, select the truths as they see them. These, finally
presented in the form of a text-book, are again accepted
as truths by students, because they believe that the
author was competent to select from the mass of litera-
ture at his command those statements which were most
probably true. In the same way the Council has at-
tempted to prove or disprove statements which seemed
questionable, while it has accepted those which, from its
general knowledge, were believed to be true. In this
matter it is needless to say that the Council has been
inclined to accept statements made by firms or personsknown to be reliable and responsible, while it has been
inclined to examine more closely the statements made
by irresponsible parties, or by those who seemed to be
inclined to exaggerate.
FORMULA NOT ALWAYS RELIABLE-EXAM PLE.
At first it was supposed that the statements of all the
legitimate manufacturing firms could be taken without
question. This supposition, however, was not well
founded, and it is here that some of us have been sadly
disappointed. We supposed that it was only the
pseudo-chemical concerns, those which are not in the
legitimate manufacturing pharmaceutical business, who
were the offenders, but in this we were mistaken. Even
the regular manufacturing concerns have among their
specialties preparations that are as fraudulent as are
any put out by the typical nostrum vendors. One old-
established house for years has had on the market a
surgical dusting powder, which it advertised as a definite
synthetic chemical compound, the result of great scien-
tific research. The published formula was worded to
mystify, and extravagant claims were made for the
product. Our chemists showed that this wonderful
preparation was a mixture containing approximately 70
per cent, of boric acid, 20 per cent, of acetanilid, with a
little thymol, bismuth, cinchonin and salol. This is by
no means an isolated case, but fortunately for one's faith
in business integrity there are at least some firms that
to physicians as scientific preparations.
COUNCIL DOES NOT RECOMMEND USE OF ARTICLES
ACCEPTED.
The acceptance of an article does not mean that the
Council recommends it; this is emphasized by printing
the following disclaimer with every publication of ac-
cepted articles :
The Council desires physicians to understand that the accept-
ance of an article does not necessarily mean a recommendation,
but that so far as known it complies with the rules adopted
by the Council.
At the inception of the work, it was decided to adopt
an extremely liberal policy and to accept a preparation
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that met the requirements, even though it might not be
considered of any great therapeutic value, or as repre-
senting anything new or important from a chemical or
pharmaceutical point of view. Later, when the Council
obtains the fuller cooperation of the profession, a higher
standard may be adopted for acceptance. In sifting the
wheat from the chaff it is sometimes advisable to have
a coarse enough sieve to let a little chaff go through, but
later on it may be desired to have the pure wheat with-
out any chaff ; then the sieve must have a finer screen.
It is presumed that physicians will think for them-
selves and use their own judgment regarding the thera-
peutic value of the preparations accepted.
THE BOOK—NEW AND NON-OFFICIAL REMEDIES.
We have been speaking of "accepting" or "approving"
preparations. Accepting for what? Approving for
what? Not for the advertising pages of The Journal,
as some have seemed to imagine. It would be absurd to
go to the trouble and expense for such a purpose. In a
sense, the Council is compiling a book, and acceptance
of an article means that it is accepted for inclusion in
this book. It will be known as "New and Non-Official
Bemedies," and will represent the actual tangible evi-
dence, or result, of the Council's work. It will contain
a description of those proprietaries which have been
approved, together with such non-proprietary drugs ashave come into more general use and are not as yet in
the Pharmacopeia. Is it necessary to present arguments
to prove that such a book is needed? Heretofore there
has been no book, in this country at least, that a physi-
cian could turn to for information regarding non-official
preparations. Every day a physician in active practice
who reads 6ees mentioned in his journals medicinalpreparations about which he knows nothing. But he'
wants to know. Where shall he look? They are not
mentioned in the Pharmacopeia, in the National Formu-
lary nor in but few, if in any, of the standard text-
books on materia medica. Heretofore he has had only
one satisfactory source of information, if it is a pro-
prietary—the manufacturer. And the information he
will receive from him will most likely be voluminous,
but too partial for unquestioning acceptance. Why not
make it unnecessary for such an inquirer to depend en-
tirely on biased information?
This book will tell him what the preparation is, what
is claimed for it, the dose, where it can be obtained, and
whether patented or trademarked. It will give him the
most favorable information consistent with truth, quot-
ing even the claims of the manufacturer, if they are not
too optimistic. But it will tell him what will not be
found in the literature sent him by the manufacturer—
it will inform him if it is liable to have untoward ef-
fects, etc. It will, in short, supply him with informa-
tion that is uninfluenced by commercialism.
It will be supplementary to the Pharmacopeia, and
will contain preparations that later will become official,
as, for instance, the various patented products which,
because they are proprietaries, are not usually admissible
to the Pharmacopeia. The last revision of the Pharma-
copeia contained preparations that, while in general use
by physicians at the time, did not appear in the
former edition. In 1893, for instance, phenacetin was
in general use, but it did not appear in the Pharma-
copeia issued in that year. If this preparation, which
is now official as acetphenetidin, is a good thing to-day,
it was then. There are a number of such preparations
already accepted that will probably be in the next Phar-
macopeia,
BOOK NOT LIMITED TO PROPRIETAEY ARTICLES.
At the beginning it was intended to include in the
book only proprietary articles, but time and experience
have shown the need of including more than these. New
drugs are continually being added to our therapeutic
armamentarium that are not in the Pharmacopeia. For
instance, a little while ago phenolphthalein, long in use
in laboratories, etc., as an indicator, was discovered to
have purgative effects, and clinical use seems to demon-
strate that it may have certain advantages over other
aperients. In fact, it is already on the market under
various proprietary names, as purgen, purgen konfect,purgatol, purgotin, laxirconfect, laxine, el zernac, etc.
The Council has decided to include this in the book.
Thus physicians will be able to learn what phenolphtha-
lein is at the outset and will not be deceived for years
into using it under various fanciful names and at many
times its cost. But, above all, they will not be misled
by the extravagant claims of commercial interests.
Hexamethylene tetramine had been known before its
value as a urinary antiseptic was discovered ; then it
was put on the market under various trademarked
names.. At the present time the Council would undoubt-
edly accept this for the book, with a description, and we
would not be bothered with a dozen or more different
names for the same article. Incidentally, I hoped a less
cumbersome name would have been given the prepara-
tion than was adopted by the Committee of Bevision of
the Pharmacopeia. Four trade names for hexamethylen-
amin already have been accepted, but this is done not
to encourage many names for the same thing, but tofurnish information. Thus a reference to the book will
disclose that Urotropin, Formin, Methaform and En-
tone are different manufacturers' names for hexamethyl-
enamin.
The permanent addition to our materia medica of
really meritorious articles has been slow, extremely
slow; but the elimination of those without merit has
been still slower. And, what is of more importance, this
elimination has been achieved at the loss not only of
money, but possibly even of human lives. The indis-
criminate and unscientific drug experimentation that
has been carried on by physicians at the behest of com-
mercial interests and without any knowledge exceptthat furnished bv such interests is not creditable. It is
hoped that this book will check this, to some extent atleast.
BOOK WILL BE AN ANNUAL.
The idea is that this book will be issued as an annual,
each revision to include the addition of new drugs andproprietary articles that are deemed worthy of admis-
sion ; those that for good and sufficient reasons should be
omitted will be left out. The descriptive matter will
also be modified as may be found necessary from thedevelopments of the year. Manufacturers are slow to
call attention to untoward results. It will be the func-
tion of the revisers of this annual to incorporate both the
favorable and the unfavorable.
Personally, as one who has had experience in general
practice, I know that it will be of immense value.
Heretofore there has been no way for the conscientiouspractitioner, the medical writer or the editor to differen-
tiate the true from the false. For these the book, "New
and Non-Official Bemedies," will furnish a reliable
guide.
While I have spoken of this book as of the future,
the fact "is the first or preliminary edition was issued
some six or eight weeks ago. This, however, is simply
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a reprint of the articles as they appeared in The Jour-
nal and is issued for two purposes : To invite criticisms
and suggestions, and, what is more important, to fur-
nish even now a book of reference for those who want
to support the Council in this movement by using only
such preparations as have been approved. Another simi-
lar edition will be issued shortly, slightly modified, with
an index and more information than appears in the first
reprint; and, of course, it will include the articles that
have been accepted since the first edition was printed.
It is probable that two or three editions of this prelim-
inary report may be issued before the official book is
published.
CAN NOT PUBLISH BLACKLIST.
It has been suggested that the Council print a list of
the preparations that have been refused recognition,
since there are many who have intimated that they
would not prescribe or recognize in any way the rejected
articles. This is impracticable : First, because the num-
ber is too large ; second, because the Council hopes that
some may reform or be withdrawn without necessitat-
ing a resort to extreme measures, and, third, because it
might and undoubtedly would involve us in lawsuits.
A blacklist is not a safe thing to make public.
The Council is publishing from time to time reports
condemnatory of preparations, with comments, but this
has to be done with great caution ; every statement mustbe verified or injustice might be done. Further, the
function of the Council is to approve rather than to con-demn. When it does condemn and publishes its con-
demnation, it is for a specific purpose, that purpose being
to educate physicians by presenting concrete examples
of the way they are being imposed on.
CHEMICAL LABORATORY.
A chemical laboratory has been established in the
Association building and is in charge of the secretary of
the Council, Professor Puckner, and an assistant. While
it is not possible to do a large amount of chemical work
in this laboratory, it will be of great advantage in many
ways.
In connection with the movement much information
relating to the general subject has been gathered. This
has been classified, indexed and made available for the
future. This, in fact, is one of the important features
of the work being done in the central office. In the past
considerable matter has been published showing the
fraudulent character of products manufactured not only
in this country, but in Germany and abroad generally.
Such matter has usually been published in drug or chem-
ical journals and has never come to the attention ofphysicians—the very ones who should have been in-
formed.
The important drug and chemical journals of the
world are taken for the laboratory, and the information
obtained from them is most valuable. It is needless to
say that hereafter physicians will be informed of mat-
ters which concern them that appear in this class ofjournals.
In connection with the laboratory is an information
bureau, in one division of which advertising literature
has been collected and classified. This includes booklets,
circulars, advertisements and write-ups in medical jour-
nals, etc., covering the last five years. The exhibit is
interesting and instructive for those who want to make
a study of this nostrum business, and will furnish texts
for future sermons in the propaganda for common sense
in therapeutics.
Another division directly related to the above is a
card index of those who have given testimonials or fur-
nished write-ups of proprietary preparations. These
cards are made up in great part from the matter on file.This division also is most interesting. While it con-
tains the names of a few excellent men, the great major-
ity are hardly known in their own locality, and yet their
opinions are accepted without question by intelligent,
well-educated practitioners. Some seem to have a habit
of giving testimonials for all kinds of things and it re-
quires considerable space to record the references. It
is encouraging to note that this exhibit is not growing sofast as it was. Evidently, testimonial giving is not sopopular as it was previous to a year and a half or two
years ago.
It is well known that while the name of a productdoes not change, the composition of the product may,
and does. To be able to show this in the future, samples
of many proprietaries are preserved, with date of receiv-
ing, etc.
COOPERATION OF OTHERS.
One favorable development is the cooperation of other
workers in similar fields. A number of chemists in uni-
versities, schools of pharmacy, etc., have volunteered to
assist, and it is expected that in the future the aid of
such men will be of great advantage in solving questions
on which they are especially well qualified to pass. Sev-
eral state and municipal boards of health are doing good
work, and exchange of information with these is now a
feature. This promises to develop in the future to the
mutual benefit of these boards and the Council. It is
hoped, in time, to interest teachers in medical colleges;
such help is sorely needed.
The advantage to the Council of having as members
Dr. Wiley, chief of the Bureau of Chemistry, and Dr.
Kebler, chief of the Drug Laboratory, has been verygreat, for it has received not only their personal aid, but
also material assistance from the departments with
which they are connected. In fact, without the aid of
these laboratories some of the work done would have
been impossible. The profession is also under great obli-
gations to Surgeon-General Wyman, who permitted Dr.
Beid Hunt to serve as a member of the Council. Through
Dr. Hunt's connection with the Hygienic Laboratory
of the Public Health and Marine-Hospital Service, and
with the permission of Surgeon-General Wyman, it has
been possible to refer certain intricate problems to that
laboratory that otherwise would have been difficult of
solution.
FOREIGN COOPERATION.
Another promising feature is the fact that the Council
is getting in touch with workers abroad. For instance,
splendid work is being done in Berlin, especially in the
investigation of the synthetic chemical compounds under
the auspices of the German Apothecary Society. This is
directed by Professor Thorns of the Pharmaceutical In-
stitute of the University of Berlin, a chemist of inter-
national standing. Correspondence with Professor
Thorns has been carried on for some months, and he has
offered to assist the Council whenever possible. At the
request of the Council, the Board of Trustees of the
American Medical Association has just elected him a
corresponding member of the Council.
Professor Cushny of the University of London has
been a corresponding member since he left this country
soon after the Council was organized.
It is hoped very shortly to get similar foreign corre-
spondents in Paris, Switzerland and in other countries.
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Such cooperation will be of great assistance in dealing
with foreign products.
One of the conditions which the Council has had to
meet is the exploitation of foreign goods by American
agents who advertise them, sometimes innocently, under
claims that are not accepted abroad. In some instances
products had been sold abroad under claims regarding
the composition that were shown to be false. Over there
the manufacturers were compelled to modify their state-
ments, but the old claims are still being made here.The Council has already secured a modification of the
literature relating to certain foreign products by calling
the American agents' attention to the fact that if such
modifications were not made the actual facts regarding
the preparation would be published.
A large number of preparations made here are adver-
tised as being made abroad. Further, some are made
abroad for the American market that have absolutely no
sale in the country in which they are made. In due
time evidences of these facts will probably be given tothe profession.
I have given a brief review of the conditions whichled to the organization of the Council, have outlined theprinciples or rules by which proprietary articles arejudged, and have spoken of the mode of procedure. Ihave not told you of the difficulties the Council has en-
countered, and I think this hardly necessary, for I am
sure all know without being told that these difficulties
have been very great.
CONDITIONS ALREADY IMPROVED.
The work has been going on for a little over two years.To all appearances there are just as many nostrums onthe market and the advertising pages of certain medicaljournals are just as well filled with this class of medi-
cines—in fact, if the truth must be told, better, and for
reasons that should be evident. But in spite of this
apparent evidence of prosperity, if one looks beneath
the surface, one will find that a change has taken place.There has been a gradual decrease in the number of
write-ups of proprietaries; there is evidence that physi-cians are thinking, that they have developed a healthy
skepticism and no longer believe all that is told them
about the wonderful cure-alls they are asked to pre-
scribe. The detail men do not have such willing andcredulous listeners. There has been a remarkable fall-
ing off in the sale of "ethical" proprietaries, especiallythose of the typical nostrum type. This is commonknowledge to those in touch with the trade. A compari-
son of the catalogues of some of the manufacturinghouses in circulation two years ago with those of to-day
will reveal the fact that not a few of the "specialties"
are missing. And the descriptive matter, formulas,
etc., of many others are different from what they were.A part of this is explained by the national Food andDTugs Act, but only a part. Many of the changes hadtaken place before this law was passed.
The influence of the Council in this connection has
been greater than will ever be known. The knowledgethat our profession is at last awake, that it has a body to
expose the frauds that may be imposed on physicians has
aroused some of the manufacturers at least to realize
that old conditions have changed. The advertising lit-
erature is scrutinized more carefully; positive cures forincurable diseases are not so common.
"WHAT ARE YOU GOING TO DO ABOUT IT?"
This much has been accomplished; and yet whatdoes it amount to compared with what must be done
before American medicine is rid of the nostrum blight?
The work has really just commenced. The exposes thathave been made and the publication of facts regarding
the nostrum business have made a large minority of thephysicians think. But it is evident that much more must
be done to arouse them to act. And this brings us to thequestion, "What is the profession going to do about it?"
The Council is purely an advisory body; there is no
national, state, county, city or any other law that will
compel the manufacturer to recognize it or to comply
with its requirements. Hence, without the support of
our profession its work will be of no permanent value.But this must be more than a passive support. Simply
endorsing the work by words, by commendation or by
that indefinable something called moral support, is well
enough so far as it goes. But if definite, permanent,
tangible results are to follow, the profession must act.If the profession does not act and does not back up thia
movement, rest assured we shall in time drop back into
the old conditions, or into even worse.
HOW THE PHYSICIAN CAN HELP.
This movement was inaugurated directly for the ben-
efit of the medical profession, and indirectly for thebenefit of the public. There is no question as to thefinal success of the propaganda, but the work will begreatly facilitated if you who are interested will :
First.—If you use proprietaries, secure the list of
approved preparations and, all things being equal, givethose in the list preference in prescribing. This list,
with a description of each article, costs but a few cents;
without the description it may be had for the asking.2Second.—Write to those whose preparations you are
using and ask if the articles have been submitted to theCouncil; if submitted and refused recognition, why?
and if not submitted, why not? Bear this in mind : The
manufacturers will recognize the Council and ask to havetheir controlled products placed in the book if physiciansinsist that they desire this; otherwise, they will do
neither.
Third.—Ask detail men who call if the preparations
represented have been approved by the Council, andif not tell them that until this has been done you do not
care to take time to examine the product.
Fourth.—Look over the advertising pages of the
medical journals you are supporting—editors and pub-lishers have great respect for the opinion of their sub-
scribers—and write and ask for a square deal in the
advertising, as well as in the reading pages.Will it be out of place for me to suggest here that the
members of the Council have a right to ask for your sup-port, when they are working absolutely without pay?Is it presumed that they will keep on indefinitely and
submit to jeers and sneers if those whose interests they
serve do not themselves do their share ?
I am sure that every intelligent physician, unless hehas some interests on the other side, believes that the
movement is a good one, and deserves all the supportthe profession can give it. I am also sure that.every one
Ox you believe this. But—what are you going to do
about it?
Let me repeat : Moral support alone will not win thisbattle.
2. For prices, see advertising page 39, this issue.
It Will Pay.—The prolongation of life by the suppression
of preventable disease is of much greater value to the state
than the cost of the means employed.—G. W. Webster, M.D., inCharities and the Commons.
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